M-protein–related disorders: MGCS

In this issue of Blood , Fermand et al report that not all cases of monoclonal gammopathy of undetermined significance (MGUS) are truly undetermined. Some patients with a low tumor burden monoclonal gammopathy (MG) have organ damage that requires therapeutic intervention, which the authors call monoclonal gammopathy of clinical significance (MGCS). 1